Tumors were stratified into low-, intermediate-, and high-risk categories using American Urological Association tumor risk criteria.21,22 Intermediate-risk tumors were further stratified into 3 mutually nonexclusive subgroups: favorable intermediate risk, low-volume favorable intermediate risk, and unfavorable intermediate risk. Favorable intermediate risk was defined as tumors with 1 intermediate-risk factor (PSA level, 10-20 ng/mL [to convert to micrograms per liter, multiply by 1.0]; grade group 2; or clinical stage of T2b) and 50% or fewer positive biopsy cores. Unfavorable intermediate risk was defined as 2 or more intermediate-risk factors, 50% or more positive biopsy cores, or grade group 3 disease.23 Low-volume favorable intermediate risk was defined as tumors with 1 intermediate risk factor and 2 or fewer positive biopsy cores.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.